(Q38307076)

2 September 2017

title

Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERalpha and ERbeta ) at AP-1 sites (English)

1 reference

2 September 2017

Weatherman RV

1

1 reference

2 September 2017

Scanlan TS

series ordinal

2

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

Journal of Biological Chemistry

2 September 2017

published in

1 reference

2 September 2017

volume

276

1 reference

2 September 2017

issue

6

1 reference

2 September 2017

page(s)

3827-3832

1 reference

Nuclear-receptor ligands and ligand-binding domains

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Therapeutic potential of selective estrogen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Allosteric effects of DNA on transcriptional regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Estrogen receptor beta: re-evaluation of estrogen and antiestrogen signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Estrogen receptor activation function 1 works by binding p160 coactivator proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

The human estrogen receptor has two independent nonacidic transcriptional activation functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Molecular basis of agonism and antagonism in the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Peptide antagonists of the human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Characterization of the Amino-terminal Transcriptional Activation Function of the Human Estrogen Receptor in Animal and Yeast Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

p300 Mediates Functional Synergism between AF-1 and AF-2 of Estrogen Receptor α and β by Interacting Directly with the N-terminal A/B Domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

A comparison of transcriptional activation by ER alpha and ER beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

Functional domains of the human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005414200

21 January 2018

Identifiers

DOI

10.1074/JBC.M005414200

1 reference

2 September 2017

1 reference